Class I U.S. Food and Drug Administration

Baxter Cefazolin in Dextrose Injection recall: Particulate matter (cardboard) found in the solution

Recall published 3 months ago

Particulate matter (cardboard) found in the solution.

Baxter Prescription & OTC drugs — recalled prescription & otc drugsBaxter Prescription & OTC drugs — recalled prescription & otc drugs (photo 2)Baxter Prescription & OTC drugs — recalled prescription & otc drugs (photo 3)
3 photos published by U.S. Food and Drug Administration with the recall notice.

The hazard: Sterility or particulate concern

Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.

What the notice says: Risk Statement: The use of the defective product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting).

Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.

Symptoms and when to call a doctor

Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.

This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.

Recall details

Recall number
D-0787-2026, D-0805-2026, D-0807-2026, D-0808-2026, D-0809-2026, D-0810-2026, D-0811-2026, D-0812-2026
Published
July 24, 2026
Risk level
Class I
Status
Ongoing
Issued by
U.S. Food and Drug Administration
Brand
Baxter
Product type
Prescription & OTC drugs
Units affected
19,032 bags; N/A
Distribution
Nationwide
Lot / code info
Lot # LD175708, Exp Date: 14-Feb-2027. — Lot # NC188678, Exp Date: 12/1/2026; Lot # NC188814, Exp Date: 12/5/2026; Lot # NC188944, Exp Date: 12/8/2026; Lot # NC193610, Exp Date: 4/21/2027, Lot # NC193665, Exp Date: 4/23/2027. — Lot # NC188692, Exp Date: 11/22/2027. — Lot # NC193764, Exp Date: 10/18/2027; Lot # NC195232, Exp Date: 11/25/2027. — Lot # NC188586, Exp Date: 02/28/2027; Lot # NC188913, Exp Date: 3/9/2027. — Lot # NC188654, Exp Date: 08/31/2027; Lot # NC188821, Exp Date: 09/30/2027; Lot # NC193658, NC193702, Exp Date: 01/31/2028. — Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028. — Lot # NC194129, Exp Date: 05/07/2028. — Lot # NC177818, Exp Date: 12/31/2026; Lot # NC188869, Exp Date: 12/31/2027. — Lot # NC177832, Exp Date: 12/31/2026; Lot # NC185417, NC185455, Exp Date: 08/31/2027; Lot # NC188593, Exp Date: 11/30/2027; Lot # NC188647, NC188685, NC188807, NC188838, NC188920, Exp Date: 12/31/2027; Lot # NC193603, NC193726, NC193788, NC193863, NC193900, Exp Date: 04/30/2028; Lot # NC194082, NC194112, NC194143, NC195157, Exp Date: 05/31/2028. — Lot # NC185424, Exp Date: 2/12/2027; Lot # NC185479, Exp Date: 2/13/2027; Lot # NC193948, Exp Date: 10/23/2027. — Lot # NC193689, Exp Date: 10/16/2027. — Lot # NC194075, Exp Date: 10/29/2027. — Lot # NC194068, Exp Date: 10/29/2027. — Lot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028. — Lot # NC193894, Exp Date: 04/25/2027. — Lot # NC193856, Exp Date: 04/18/2028.

Products covered by this recall

Cefazolin in Dextrose Injection

What the company announced

July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.

Risk Statement: The use of the defective product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting). Systemically, foreign particles infused intravenously can cause systemic activation of the immune system, organ dysfunction, and hemolysis (breakdown of blood cells). To date, Baxter has not received any reports of adverse events related to this issue.

Affected Product:

This product is used intravenously to treat bacterial infections or prevent them during surgery

  • Product Code: 2G3508 · Product Description: Cefazolin in Dextrose Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix · Lot Number: LD175708 · Expiration Date: 14-Feb-2027 · NDC Number: 0338-3508-41

The affected lots can be identified by locating the lot number and expiration date on the front of the product package and the label attached to the carton, as shown in the images below.

The impacted product was distributed from 3/25/2025 to 6/30/2025 in the United States.

Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process. Baxter is contacting customers with instructions on how to identify and return the impacted product.

For general questions regarding this communication, please contact Baxter Healthcare Center for Service at 888-229-0001 between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online: www.fda.gov/medwatch/report.htm

Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

The United States Food and Drug Administration (FDA) has been notified of this action.

Reproduced from the company announcement posted on fda.gov. Links and contact forms in the original are not repeated here; the official notice below has them.

Check your product

The notice names 77 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.

Lot or batch code

Usually ink-stamped near the seam, the cap or the bottom of the pack.

  • LD175708
  • NC188678
  • NC188814
  • NC188944
  • NC193610
  • NC193665
  • NC188692
  • NC193764
  • NC195232
  • NC188586
  • NC188913
  • NC188654
  • NC188821
  • NC193658
  • NC193702
  • NC193672
  • NC193795
  • NC194198
  • NC194129
  • NC177818

Best-by / use-by date

Printed beside the lot code, not on the price sticker.

  • 14-Feb 2027
  • 14-Feb-2027
  • 12/1/2026
  • 12/5/2026
  • 12/8/2026
  • 4/21/2027
  • 4/23/2027
  • 11/22/2027
  • 10/18/2027
  • 11/25/2027
  • 02/28/2027
  • 3/9/2027
  • 08/31/2027
  • 09/30/2027
  • 01/31/2028
  • 04/30/2028
  • 05/31/2028
  • 05/07/2028
  • 12/31/2026
  • 12/31/2027

NDC number

On the carton and again on the bottle or blister label.

  • 0338-3508-41
  • 0338-3552-48
  • 0338-0714-24
  • 0338-3612-50
  • 0338-5197-41
  • 0338-9557-12
  • 0338-9640-12
  • 0338-9648-12
  • 43066-016-10
  • 43066-360-20
  • 0338-3814-50
  • 0338-9549-50
  • 0338-4114-50
  • 43066-995-24
  • 0338-9647-12
  • 0338-3583-01
  • 0338-0718-12

Model or item number

On the rating label, the box or the instruction sheet.

  • 2G3508

Package size

Match the net weight or the piece count on the front of the pack.

  • 100 mL
  • 20 mg
  • 200 mL
  • 5 mg
  • 500 mg
  • 50 mL
  • 10 mg
  • 600 mg
  • 12 mg
  • 80 mg
  • 0.8 mg
  • 40 mg
  • 0.2 mg
  • 360 mg
  • 1.8 mg
  • 900 mg
  • 18 mg
  • 000 mg
  • 1000 mL

Codes are lifted verbatim from the FDA — Company recall announcements notice. A code that is missing here may still be covered — the official notice is the complete list.

What to do about Sterility

Baxter — Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.

  1. Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
  2. Call your prescriber or pharmacy today about a replacement from an unaffected lot — do not simply skip doses of a medicine you depend on.
  3. If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
  4. Report any infection or reaction you think the product caused to FDA MedWatch.

What the company owes you

A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.

  • The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
  • Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
  • Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
  • Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.

Company contact: Baxter International Inc. — Consumers: (888) 229-0001 — Media: Brenna Byrne, (224) 948-5353, [email protected]

The official notice

This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.

Open the FDA — Company recall announcements record U.S. Food and Drug Administration recalls

Questions people ask about this recall

Why was Baxter prescription & otc drugs recalled?

Particulate matter (cardboard) found in the solution. Risk Statement: The use of the defective product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting).

How do I know if I have the recalled product?

Match the codes printed on your package against the notice: lot code LD175708, NC188678, NC188814; best-by date 14-Feb 2027 or 14-Feb-2027; model number 2G3508. If the code on your package is not on that list, your unit is outside the recall.

What should I do with it right now?

Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.

Can I get my money back?

The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.

Where was the recalled product sold?

It was distributed nationwide.

Related recalls